Interested in specific Information?

Filter what you see here

General MM,   Patients non-eligible for transplant,  Patients eligible for transplant,   & 2 more

Quick poll

COMy 2018 | An Overview

COMy 2018 | An Overview

Closes May 17, 2018

Patients eligible for transplant,   Patients non-eligible for transplant,  Relapsed/refractory patients

Quick poll

Galinpepimut-S granted FDA orphan drug designation

Closes May 11, 2018

Patients eligible for transplant,   Patients non-eligible for transplant

Quick poll

Daratumumab approved by FDA for frontline use

Closes May 8, 2018

General MM

Quick poll

Time to plateau shows prognostic value in NDMM

Time to plateau shows prognostic value in NDMM

Closes May 7, 2018

General MM

Quick poll

Safety of 90-minute daratumumab infusion

Closes May 1, 2018

General MM,   Patients eligible for transplant,  Patients non-eligible for transplant,  Relapsed/refractory patients

Quick poll

Microfluidic device improves detection of genetic abnormalities and…

Closes Apr 30, 2018

General MM

Quick poll

Risk of progression to MM: a long-term follow-up of MGUS patients

Risk of progression to MM: a long-term follow-up of MGUS patients

Closes Apr 27, 2018

Patients eligible for transplant

Quick poll

New imaging methodology enables rapid assessment of transplant success in…

Closes Apr 25, 2018

General MM

Quick poll

The concept of a cure in MM: a comparison of survival outcomes

Closes Apr 22, 2018

Patients eligible for transplant

Quick poll

Validation of the R-ISS for stratification of transplant-eligible MM…

Validation of the R-ISS for stratification of transplant-eligible MM patients

Closes Apr 19, 2018

General MM

Quick poll

Detection of MM-associated translocations and mutations in IGLL5

Closes Apr 17, 2018

General MM

Quick poll

Treatment to suppression of focal lesions in NDMM is an important…

Closes Apr 16, 2018

General MM

Quick poll

High BMI in early and late adulthood is a risk factor for MM

High BMI in early and late adulthood is a risk factor for MM

Closes Apr 12, 2018

Relapsed/refractory patients

Quick poll

Response kinetics and treatment outcomes in RRMM

Closes Apr 9, 2018

Patients eligible for transplant

Quick poll

EBMT 2018 | Pre-transplant Induction in MM

Closes Apr 5, 2018
A global online educational platform sharing the latest research and emerging treatment information in multiple myeloma

Latest Medical Information

Relapsed/refractory patients

Selinexor receives FDA fast track designation 

Apr 13, 2018
General MM,   Relapsed/refractory patients,   & 1 more

Denosumab approved for MM in Europe

Apr 11, 2018

Latest Expert Opinions

General MM,Patients eligible for transplant,Patients non-eligible for transplant,Relapsed/refractory patients

Following NICE guidelines | An interview with Ceri Bygrave

Mar 29, 2018
English & Spanish

Latest Biology

Latest Drug Updates

Patients eligible for transplant,Patients non-eligible for transplant,Relapsed/refractory patients

Galinpepimut-S granted FDA orphan drug designation

May 11, 2018
Patients eligible for transplant,Patients non-eligible for transplant

Daratumumab approved by FDA for frontline use

May 8, 2018
Relapsed/refractory patients

Selinexor receives FDA fast track designation 

Apr 13, 2018

Recently updated Licenses

Where we are next

The 4th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy)

May 3-5, 2018 | Paris, France

The Multiple Myeloma Hub will be attending the 2018 Controversies in Multiple Myeloma meeting in Paris from 3-5 May 2018. Some of the biggest names in Multiple Myeloma will gather together to discuss the latest advances in treatment and guidelines for disease management, in the form of talks, case studies, and active debate. Stay tuned to the MM Hub to follow for our first-hand coverage.

Event Website

Map Data
Map data ©2018 Google
Map DataMap data ©2018 Google
Map data ©2018 Google

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology